Cite
HARVARD Citation
Arzimanoglou, A. et al. (n.d.). Evaluation of long-term safety, tolerability, and behavioral outcomes with adjunctive rufinamide in pediatric patients (≥1 to <4 years old) with Lennox-Gastaut syndrome: Final results from randomized study 303. European journal of paediatric neurology. pp. 126-135. [Online].